Patents by Inventor Sergi Pavon Fernandez

Sergi Pavon Fernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR SYNTHESIZING THYMOSINS
    Publication number: 20110166071
    Abstract: The invention relates to a method for obtaining thymosins and/or the pharmaceutically acceptable salts thereof by means of solid-phase synthesis on polymeric supports, which comprises the steps of linearly synthesizing the thymus-derived peptides in solid phase, incorporating at least one Thr or Ser in the sequence, in pseudoproline dipeptide form, obtaining the thymosins by treating the peptidyl resin with trifluoroacetic acid, and purifying the thymosins by RP-HPLC. The present invention also protects the isolated and/or purified compound obtained by means of said method and also the use thereof in the preparation of a medicinal product.
    Type: Application
    Filed: April 25, 2007
    Publication date: July 7, 2011
    Inventors: Jimena Fernandez Carneado, Berta Ponsati Obiols, Javier Clemente Rodriguez, Raimon Rubires Ferrer, Sergi Pavon Fernandez
  • Stable pharmaceutical formulation for intravenous or intramuscular administration of active peptide compounds
    Patent number: 6521599
    Abstract: A stable pharmaceutical formulation for intravenous or intramuscular administration of Octreotide, which is characterized in that the vehicle for injection of the peptide or pharmaceutically acceptable salts thereof contains glycine in concentrations ranging from 10 to 60 mM and aqueous solution of hydrochloric acid in sufficient quantity to adjust the pH of the formulation to values between 3.0 and 4.2.
    Type: Grant
    Filed: October 10, 2001
    Date of Patent: February 18, 2003
    Assignee: Lipotec, S.A.
    Inventors: Berta Ponsati Obiols, Gemma Jodas Farres, Francisco Javier Clemente Rodriguez, Sergi Pavon Fernandez, Jordi Bacardit Cabado
  • Pharmaceutical formulation for intravenous or intramuscular octreotide administration
    Publication number: 20020128204
    Abstract: A stable pharmaceutical formulation for intravenous or intramuscular administration of Octreotide, which is characterised in that the vehicle for injection of the peptide or pharmaceutically acceptable salts thereof contains glycine in concentrations ranging from 10 to 60 mM and aqueous solution of hydrochloric acid in sufficient quantity to adjust the pH of the formulation to values between 3.0 and 4.2.
    Type: Application
    Filed: October 10, 2001
    Publication date: September 12, 2002
    Inventors: Berta Ponsati Obiols, Gemma Jodas Farres, Francisco Javier Clemente Rodriguez, Sergi Pavon Fernandez, Jordi Bacardit Cabado